---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-036109"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2026-08-05T12:30:20+00:00"
generated_at: "2026-08-05T12:35:29.479225+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Dermata announces Aug 25 launch of Tome Foundational Treatment at $178 per set

## Summary
- First commercial product Tome Foundational Treatment launches August 25, 2026; waitlist gets early preorder access.
- Four once-weekly treatments per set, priced at $178 (approx $45/treatment), sold exclusively at tomeskincare.com.
- Company shifts to commercialize skincare products, reducing regulatory burdens and expanding consumer market.

## SEC filing metadata
- accession: 0001493152-26-036109
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2026-08-05T12:30:20+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000149315226036109/0001493152-26-036109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000149315226036109/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-036109
- JSON: https://secwatch.observer/filing/0001493152-26-036109.json
- Plain text: https://secwatch.observer/filing/0001493152-26-036109.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.